Zentalis Pharmaceuticals, Inc. (ZNTL) | Jive Data

Google Sheets Add-onSheets Account

Profile Financials SEC Filings Insider Transactions Ownership

Loading ZNTL…

Zentalis Pharmaceuticals, Inc. (ZNTL) | Jive Data

Google Sheets Add-onSheets Account

Profile Financials SEC Filings Insider Transactions Ownership

SEC filing

Zentalis Pharmaceuticals, Inc.

ZNTL · CIK 1725160

4 · Feb 10, 2026 · Bruns Ingmar sold 3,297 shares at $2.43/share ($7,998)

4

Bruns Ingmar sold 3,297 shares at $2.43/share ($7,998)

Filed: Feb 10, 2026
Period: Feb 6, 2026
Accession: 0001838041-26-000004
Filer: Zentalis Pharmaceuticals, Inc.

View on SEC.gov All SEC filings

Filing document

FORM 4

xslF345X05/wk-form4_1770775846.xmlSEC.gov

Other files

Graphics and non-inline formats (not embedded below).

4FORM 4wk-form4_1770775846.xml
Open SEC.gov